----

**CERTIFICATIONS**

**EXHIBIT        31.2**

| (a)   | Designed such disclosure controls and procedures,                or                caused such disclosure controls and procedures to be designed under                our                supervision, to ensure that material information relating to the                registrant, including its consolidated subsidiaries, is made known                to us                by others within those entities, particularly during the period in                which                this quarterly report is being prepared; |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)   | Evaluated                  the effectiveness of the registrant’s disclosure controls and procedures                  and presented in this report our conclusions about the effectiveness                  of                  the disclosure controls and procedures, as of the end of the period                  covered by this report based on such evaluation;                  and |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (c)   | Disclosed                  in this report any change in the registrant’s internal control over                  financial reporting that occurred during the period covered by                  this                  quarterly report that has materially affected, or is reasonably                  likely to                  materially affect, the registrant’s internal control over financial                  reporting; and |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (a)  | All                  significant deficiencies and material weakness in the design or                  operation                  of internal control over financial reporting which are reasonably                  likely                  to adversely affect the registrant’s ability to record, process, summarize                  and report financial information;                  and |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)   | Any                  fraud, whether or not material, that involves management or other                  employees who have a significant role in the registrant’s internal control                  over financial reporting. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                                   |                                     |                                    |
|----------------------------------------------------------------------------------------|------------------------------------------|-----------------------------------------|
|                                                                                   | **OCCULOGIX,                  INC.**     |
|                                                                              |                                |                               |
| Date:     November                  10,                  2005 | By:                            | /s/ John                  Y. Caloz |
|                                                                                   | Chief                  Financial Officer |
|                                                                                   |                                     |

----